Business
GlaxoSmithKline hoping to deliver Australia’s next COVID treatment – Sydney Morning Herald
The pharma giant has started the approvals process for a drug similar to what Donald Trump received.
GSK announced last year it plans to close its Melbourne manufacturing site in Boronia at the end of 2022 after 50 years. The companys research on the COVID treatment has all taken place overseas, with Australias low case numbers meaning it is difficult to run trials for treatments here.
Australia is currently focused on the rollout of coronavirus vaccines, but the local biotech sector has long said there needs to be more treatment options for patients who present with the virus – particularly as…
-
Noosa News13 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General14 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General12 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
Noosa News15 hours agoThe Best Things to Do in Brisbane This New Year’s Eve